CARDIAC RSK3 INHIBITORS, LLC — SBIR/STTR Competitive Profile

Aggregate SBIR/STTR award history for CARDIAC RSK3 INHIBITORS, LLC, built entirely from public federal award records. Free competitive intelligence — no login required.

Phase mix

Funding agencies

Awards by year

Places of performance

Firms like CARDIAC RSK3 INHIBITORS, LLC

See the companies with the most overlapping technology domains and funding agencies, ranked by a weighted-overlap similarity score.

Recent awards

AwardAgencyAmountProgramStart
1R44HL167349-01A1 Department of Health and Human Services $1,978,293 SBIR · Phase II 2023-09-14
1R44HL158318-01A1 Department of Health and Human Services $436,929 SBIR · Phase I 2021-09-01
1R44HL147631-01 Department of Health and Human Services $332,445 SBIR · Phase I 2019-07-01

Frequently asked questions

How many SBIR/STTR awards has CARDIAC RSK3 INHIBITORS, LLC won?

CARDIAC RSK3 INHIBITORS, LLC has won 3 SBIR/STTR awards worth $2,747,667 in the public federal award records SBIR Signal tracks, including 2 Phase I and 1 Phase II award(s).

Which agencies fund CARDIAC RSK3 INHIBITORS, LLC?

CARDIAC RSK3 INHIBITORS, LLC's awards come from 1 agency on record; its top funder is Department of Health and Human Services.

What technology areas does CARDIAC RSK3 INHIBITORS, LLC work in?

Based on its award history, CARDIAC RSK3 INHIBITORS, LLC works in a range of technology areas.

How do I find firms similar to CARDIAC RSK3 INHIBITORS, LLC?

Sign in and open the 'firms like this' view on the profile to see the companies with the most overlapping technology domains and funding agencies.